The inhibition of Hsp90 or the PI3K/AKT/mTOR pathway significantly reduces radiotherapy-induced HIF-1α expression and diminishes vascular endothelial growth factor (VEGF) levels, weakening angiogenesis and decreasing the radioresistance of lung cancer cells. This evidence concerns the gene VEGFA and lung cancer.